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CHAPTER I 
1. INTRODUCTION 
1.1 Immune system 
Immune system is a complex organization of white blood cells, antibodies, 
and blood factors that protects the body from foreign invaders, while simultaneously 
maintaining self-tolerance (Baniyash, 2006). A series of specialized epithelial and 
stromal cells also provide the anatomic environment which regulate various functions 
of immune system by secreting several critical factors. The immune system is a 
network of cells, tissues, and organs that work together to defend the body against 
attacks by “foreign” invaders. These are primarily microbes (germs)—tiny, infection-
causing organisms such as bacteria, viruses, parasites, and fungi. Because the 
human body provides an ideal environment for many microbes, they try to break in. It 
is the immune system’s job to keep them out or, failing that, to seek out and destroy 
them. 
 The immune system is a system of biological structures and processes within 
an organism that protects against disease. Disorders of the immune system can 
result in autoimmune diseases, inflammatory diseases, cancer and 
immunodeficiency1.  Immunomodulation is a procedure which can alter the immune 
system of an organism by interfering with its functions; if it results in an enhancement 
of immune reaction, it is named as an immunostimulative drug which primarily 
implies stimulation of non-specific system. Immunosuppressant implies mainly to 
reduce resistance against infections, stress and may occur on account of 
environmental or chemotherapeutic factors. Immunostimulation and 
immunosuppressions both need to be considered in order to regulate the normal 
immunological functioning. Hence both immunostimulating agents and 
immunosuppressing agents have their own standing, so search for better agents 
exerting these activities is becoming the field of major interest all over the world. 
A number of Indian medicinal plants and various ‘Rasayana’ have been 
claimed to possess Immunomodulatory activity2.The use of plant products as 
immunomodulators is still in a developing stage. A variety of plant-derived materials 
such as polysaccharides, lectins, peptides flavonoids and tannins have been 
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reported to modulate the immune system3. Since ancient times, several diseases 
have been treated by administration of plant extracts based on traditional medicine4. 
Natural adjuvants, synthetic agents, antibody reagents are used as 
immunosuppressive and immunostimulative agents. But there are major limitation to 
the general use of these agents such as increased risk of infection and generalized 
effect throughout the immune system5. 
                   The immune system that humans have evolved is, however, not perfect and 
we discuss some of these imperfections at the end of this chapter. The immune 
system is a very effective killing machine, and if it goes wrong it can cause severe 
disease and even death of its host. To cover these latter areas we first consider how 
the immune system is able to discriminate between what needs to be eliminated and 
what does not – particularly in the case of adaptive immunity, which has evolved to 
recognize molecular structures largely at random. We then introduce the different 
ways in which the immune system can cause damage if it becomes directed not to 
infectious agents, but to otherwise harmless targets, including many inert substances 
around us and within the tissues of the host itself. We discuss the problems of 
transplants (some of which can even attack their hosts) and why the immune system 
fails to reject malignant tumors (cancer). Finally, we turn from problems to solutions 
and introduce two areas in which either the intact immune system or components of 
immunity can be harnessed for our own benefit and from which tools can be derived 
to treat disease. 
Different types of cells and molecules are involved in the initiation of innate 
and adaptive immune responses although, as mentioned above, their interaction is 
essential in defense against most infectious agents. So what do the innate and 
adaptive arms of immunity do in general terms? Broadly speaking we can view some 
components of the innate immune system as being involved in the detection of 
“harmful” things that represent “danger” to the organism, such as general classes of 
microbes that may have infected the host. Other components then endeavor to 
eliminate the microbe. In contrast, the adaptive immune system can discriminate 
very precisely between individual microbes, even of the same type, but can generally 
only make a response if it has been informed by the innate system that what is being 
recognized is “dangerous”. If so, adaptive responses may then help to eliminate the 
microbe, if it has not already been eradicated during the earlier innate response. 
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Recognition of infectious agents is essential for any form of immunity and thus for 
host defense against them. 
The key components of the innate immune system include cells such as 
phagocytes and soluble molecules such as complement. This work together to sense 
the presence of infection. The recognition of potentially dangerous microbes usually 
leads to the generation of inflammation, familiar to us all. One way of viewing this is 
that the innate immune systems of multi-cellular organisms can generate .alarm. 
signals in response to danger, and that some of these signals cause inflammation 
The key components of the adaptive immune system are the lymphocytes. It 
is convenient at this stage to divide these into two main groups (other types do 
exist). One group is the T lymphocytes (T cells) which have evolved to interact with 
other cells. The other is the B lymphocytes (B cells) which are the precursors of cells 
that can make soluble antibodies. The recognition of molecules from infectious 
agents by lymphocytes is mediated by their specialized antigen receptors, which are 
not present on cells of innate immunity 
The lymphocyte is the basic cell responsible for both humoral and cellular 
immunity. This cell in resting stage is small (6μm in diameter), with a high nuclear-to-
cytoplasmic ratio, indicative of its lack of activity. A pool of recirculating lymphocytes 
passes from the blood into the lymph nodes, spleen, and other tissues and back to 
the blood by the major lymphatic channels such as the bone marrow and the thymus. 
The bone marrow hemopoietic stem cells are the ultimate origin of 
erythrocytes and all leukocytes, including the lymphocytes. Many lymphocytes pass 
through the thymus where they become processed by the hormonal 
microenvironment prior to release. These lymphocytes are now called as thymus-
derived lymphocytes, T lymphocytes, or T-cells the majority of the bone marrow-
derived lymphocytes which do not enter or become processed by the thymus are 
called B cells. 
1.2 Immune mechanisms 
The introduction of foreign substance (antigen) into the body provokes an 
immune reaction & for this it is essential that the body recognize it as “non self”. 
Most antigens are first ingested & concentrated by the macrophages, & later 
passed to the nearly lymphocytes. The immune response is initiated by the 
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interaction of the antigen with the receptors on the surface of the lymphocytes, and 
the response may be of true types 
1.2.1 Humoral immunity 
Humoral immunity is the aspect of immunity that is mediated by secreted 
antibodies, produced in the cells of the B lymphocyte lineage (B cell). B cells express 
a unique B cell receptor (BCR), in this case, an immobilized antibody molecule. The 
BCR recognizes and binds to only one particular antigen. 
A critical difference between B cells and T cells is how each cell "sees" an 
antigen. T cells recognize their cognate antigen in a processed form - as a peptide in 
the context of an MHC molecule, while B cells recognize antigens in their native 
form. Once a B cell encounters its cognate (or specific) antigen (and receives 
additional signals from a helper T cell (predominately Th2 type), it further 
differentiates into an effector cell, known as a plasma cell. 
1.2.2 Cell mediated immunity 
Cell-mediated immunity is an immune response that does not involve 
antibodies but rather involves the activation of macrophages, natural killer cells (NK), 
antigen-specific cytotoxic T-lymphocytes, and the release of various cytokines in 
response to an antigen. Historically, the immune system was separated into two 
branches: humoral immunity, for which the protective function of immunization could 
be found in the humor (cell-free bodily fluid or serum) and cellular immunity, for 
which the protective function of immunization was associated with cells. 
1.2.3 Innate Immune Responses 
Immune cells, non-immune cells and non-cellular systems all participate in 
initiating an innate immune response. Why is it called “innate”? It’s innate because it 
depends on intrinsic systems that are built into your body to recognize danger and 
there is no learning or adaptation involved8. 
1.3 Receptors of the Innate Immune Response 
In order to detect PAMPs or DAMPs, cells need tools to recognize them. 
These tools are protein receptors that can be found on the cell surface as well as 
internally. In general, they are called pattern recognition receptors or PRRs. These 
receptors come in families consisting of multiple members. Receptors that recognize 
PAMPs include the Toll-like receptors (TLRs), the C-type lectin receptors (CLRs), the 
NOD-like receptors (NLRs), RIG-I-like receptors (RLRs) and invariant T cell 
receptors.9, 10 
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DAMP receptors are not so clear-cut. TLRs have been implicated as well as 
the receptor for advanced glycation endproducts (RAGE). Also the purinergic 
receptors that recognize ATP would also fall into this category.11 
1.3.1 Toll-like Receptors 
These receptors are found on most cells of the body. They recognize a variety 
patterns associated with a number of pathogens including virus-associated nucleic 
acids; bacterial-associated cell wall components, protein, ribosomal RNA and DNA; 
and protozoan-associated proteins. The majority is found extracellular, but a number 
are also found intracellular. When stimulated they activate the transcription factor 
NFκB, which is essential for activating a cell’s immune functions and set off a signal 
cascade via MAP kinase (a phosphorylating enzyme).12 
1.3.2 C-type Lectin Receptors 
            These receptors are specialized in recognizing carbohydrate structures, such 
as the sugar mannose, which is a common component of fungal cell walls13.Thus, 
these receptors are found on the cell surface. Though much of the literature involves 
their expression on immune cells, reports of CLR variants on non-immune cells can 
also be found14. On the phagocytic cells, it is known that they can participate in 
endocytosis, the engulfment of particles or pathogens and respiratory burst15. Some 
also appear to initiate signal cascades similar to TLRs leading to NFκB and MAP 
kinase activation, but it also appears that they can work in concert with TLRs, 
enhancing or inhibiting their function16. 
1.3.3 NOD-Like Receptors 
These receptors are found in the cytoplasm of cells. Traces of their 
expression is found in most organs of the body and it is probably safe to say that 
most immune cells express at least some members of the NLR family. These 
receptors are designed to detect intracellular bacteria and, possibly, endogenous 
stress molecules and allow the cell to produce one of the most potent inflammatory 
mediators, Interleukin (IL)-1ȕ17. 
 
1.3.4 RIG-I-like Receptors 
Like NLRs, RLRs are also found in the cytoplasm of a cell. Instead of detecting 
bacterial products, these receptors help detect viral infection.18 They do this by 
binding to RNA produced during viral replication. Working together with nucleic-acid 
detecting TLRs, they lead to NFκB, MAP kinase activation and activation of 
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Interferon regulatory factor (IRF) transcription factors19.The IRF transcription factors 
are necessary to produce cytokines specialized for the control of viral infections. 
Cytokines are small, secreted proteins used as messengers between cells, which 
alert surrounding immune cells about danger. 
 
Fig No. 1.3A: Invariant Receptors of the Innate Immune System 
 
 
 
 
1.4 Immune Cells of the Innate Response 
Under epithelial layers are resident macrophages, neutrophils, dendritic cells, NK 
cells, mast cells and a number of T cell-related cells20. 
1.4.1 Macrophages  
The name macrophage is derived from Greek, meaning “large eaters”. Their 
main function is to phagocytize (engulf) pathogens and particles. It does this by 
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wrapping its plasma membrane around particles until they are enveloped and 
pinched off to form an endosome inside the cell. Once inside the cell, the endosome 
merges with a lysosome that contains en Macrophages also have the ability to 
generate a “respiratory burst”, which is a release of oxygen radicals that damage 
surrounding pathogens and cells. They also can alert and attract other immune cells 
through inflammatory cytokine release21. 
1.4.2 Neutrophils 
Neutrophils are the main foot soldiers of the innate immune response and are 
certainly the most abundant. They also have a wide arsenal of tools to deal with 
invaders. Like macrophages, neutrophils can phagocytize particles, release a 
respiratory burst and produce inflammatory cytokines. Unlike macrophages, 
neutrophils have the internal caches of anti-microbial substances called granules22. 
1.4.3 Dendritic Cells 
Dendritic cells are also phagocytic cells, but they have the special ability of 
initiating an adaptive immune response (will be discussed later).23 Unlike neutrophils 
and macrophages, Dendritic cells or DCs are not simple foot soldiers. Instead, they 
function more as spies and provide intelligence about invaders to T cells through a 
phenomenon called “antigen presentation” and through cytokine production24. 
1.4.4 NK Cells 
The NK stands for Natural Killer and the name implies their function. These 
cells, however, do not kill pathogens directly. Instead, these cells have the ability to 
recognize when other cells are harboring internal pathogens using special receptors 
and then kill them. Situations where this might occur is during viral and mycro 
bacterial infections. These pathogens easily reside in host cells, finding ways to 
block lysosome fusion and their own destruction25. 
 
 
1.4.5 Mast Cells 
Mast cells are the cells that are responsible for the classic signs of 
inflammation, which include redness, swelling and heat. Though well known for their 
association with allergy, they also can detect PAMPs and DAMPs through receptors 
and become immunologically active. Mast cells exert their functions mainly through 
cytokine and granule release. Unlike neutrophils, which release antimicrobial 
substances, mast cells release histamine and heparin. Histamine is well known for 
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its vasodilator function and ability to allow fluid to leak between cells, causing 
redness and swelling. It also causes inflammatory itching by triggering neurons 
(unmyelinated C-fibers) responsible for the itch feeling. Heparin prevents blood 
coagulation26.27. 
1.4.6 T Cell-like cells 
Most T cells are part of the adaptive immune response as they have adaptive 
T cell receptors (receptors that learn to recognize pathogens). NK T cells and Ȗį T 
cells, however, use invariant T cell receptors (receptors that do not rearrange) or 
semi-invariant T cell receptors and participate in the innate immune response. 
NK T cells are similar to the NK cells mentioned above. Not so much in 
function, but more in how they look. These cells share many of the same surface 
protein markers. NK T cells, however, do not kill compromised cells. Instead, they 
are quick cytokine producers. In doing so, they quickly notify all surrounding cells 
that there is problem when they recognize PAMPs presented to them via dendritic 
cells28. 
The Ȗį T cells are important for innate immune reactions and the adaptive 
immune response as they have invariant and variant T cell receptors. Their precise 
function remains unclear, but they can secrete cytokines and, like the NK T cells 
above, participate in alerting and strengthening local immune responses29. 
i) Non-cellular Systems of the Innate Immune Response 
              Besides cells, there are also defenses in your body that are ready to react 
to pathogens as soon as they are encountered, much like booby traps. These 
systems rely on small proteins that are found within the bodily fluids. 
 
ii) Complement System 
The liver synthesizes the proteins of the complement system and they work in 
concert to aid in phagocytosis, bacteria lysing and immune cell attraction. One can 
visualize it as a self-assembling machine that starts to assemble as soon as the first 
proteins are bound and in place. The complement “machine” is known to be initiated 
by three different pathways: the classical pathway, the alternative pathway and the 
lectin pathway. The classical pathway is triggered when antibodies are bound to a 
pathogen. The alternative pathway is triggered when the victim is unable to block the 
cascade (normal cells can, while pathogens cannot). The lectin pathway uses free 
 9 
 
lectin proteins (lectins are proteins that bind sugars) to bind sugars associated with 
bacterial cell walls). 
iii) Acute Phase Proteins 
These proteins are also produced by the liver and especially during 
inflammation when proinflammatory cytokines are produced. Many are designed to 
coat pathogens and have chemotactic properties (have the ability to attract cells). 
Some inhibit microbial growth by sequestering iron from the environment. The lectins 
from the lectin pathway of complement activation are considered acute phase 
proteins30. 
iv) Anti-microbial Peptides 
Often called “defenses”, these peptides function as natural antibiotics and our 
produced by cells that guard the external surfaces and internal surfaces such as the 
skin and the gastrointestinal system. In the skin, the main sources are keratinocytes, 
mast cells, neutrophils, sebocytes and eccine epithelial cells. In the intestines, one of 
the main producers are the Paneth cells of intestinal crypts31. 
v) Adaptive Immune Responses 
The adaptive immune response is what gives individuals long-term immunity 
to a pathogen after vaccination. Instead of relying on germ-line encoded receptors 
for the recognition of pathogens like the innate immune system, it depends on the 
development of receptors that can recognize any unique molecular characteristic of 
pathogens32. The molecules that can be recognized are called antigens. The 
classical definition of an antigen is any molecule that can provoke the development 
of antibodies. A better, and less-confusing, definition is a molecule that can be 
recognized by the adaptive immune system. The molecules are often protein 
peptides (small pieces of protein). But, they can also be sugars, lipids and other 
small molecules under the right circumstances. The main players of the adaptive 
immune response are the T cells (both T helper cells and cytotoxic T cells) and the B 
cells. 
vi) The Bridge Between Innate and the Adaptive Responses: Dendritic Cells 
During the innate immune response, the first steps are taken to initiate an 
adaptive immune response. The main cells responsible for this step are the DCs that 
we described earlier. As we mentioned before, DCs are a phagocytic cell type. This 
means that they have the ability to engulf pathogens/particles in endosomes and 
later fuse these vesicles to lysosomes for destruction. The process, however, does 
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not stop here. Instead of just disposing of the pathogen/particle waste, the DC, 
instead, uses these parts to educate T helper cells about the pathogens. It does this 
by traveling from the location where it picked up its parcel to the local lymph node, 
where it finds T helper cells. Once there, it presents the pathogen-associated 
peptides on its surface using molecules called MHC class II molecules and provides 
information to T cells about how it should respond using surface molecules called co 
stimulatory molecules and cytokines. Educating T helper cells is the first step 
towards initiating an adaptive immune response. 
1.5 T helper Cells and Their Education 
T helper cells or the cells are crucial cells in the adaptive immune response and they 
are characterized by a surface protein called, CD4. They hold the key to initiating the 
functions of cytotoxic T cells33 and B cells34. Furthermore, they can also increase the 
efficacy of macrophages.  
The cells interact with the MHC class II/peptide complexes presented by 
antigen presenting cells through its receptor, called the T cell receptor (TCR). If a T 
cell has never before seen antigen, it is called a naïve T cell. In this situation, the T 
cell will need instruction from a professional antigen 13 presenting cells, usually a 
DC, about how to perform its function. DCs do this through cell surface proteins call 
0co-stimulatory molecules and through cytokine expression. This process is consists 
of three main signals. The first signal is the antigen recognition; the second signal is 
co-simulation and the third cytokine exposure. This whole process is referred to as 
“priming” of the naïve T cell. Once primed, the T cells begin to divide; a process that 
is referred to as expansion or proliferation35.  
The most important set of co-stimulatory molecules is CD80 or CD86 on the 
DC and CD28 on the T cells. This second signal is necessary to tell the cell that 
there is a problem. If signal one is given without this second signal, the T cell will 
assume that the antigen is actually harmless and become non-responsive in a 
process called “anergy”36. Only a DC that has encountered a PAMP or another 
danger signal will express CD80 or CD86 on its surface reassuring the Th cell that 
there is, indeed, a problem.  
Signal three is the secretion of cytokines of the DC. There are several 
cytokines important for the cell education. They most important ones are IL-4, IL-12, 
IL-6, TGFȕ and IL-10. Th cells will differentiate into different types of the cells 
depending on which cytokines prevail. The main types of the cells are T helper 1 
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(Th1) cells, T helper 2 (Th2) cells, T helper 17 (Th17) cells, and induced regulatory T 
cells (iTreg).  
1.5.1 The Cell Subtypes  
Each the cell subtype has its own unique set of skills. One could almost see 
differentiation as an occupation. Just like an athlete will choose to develop her body 
and a scientist will choose to develop her mind. In humans, these choices are 
reflected at the level of gene transcription and protein expression. The athlete will 
stimulate muscle growth and the scientist develops the cerebral cortex of the brain. 
It’s the same for the cell differentiation. The four main subtypes of the cells are listed. 
There are, however, rare forms that have been observed that are not listed and The 
cells, much like humans, can fall into gray areas between the stereotypes.  
i) T helper 1 Cells 
 The Th1 path is chosen when T cells are exposed to IL-12 during priming. 
Th1 cells are characterized by the production of the cytokine, interferon-Ȗ (IFNȖ) and 
the expression of the master transcription factor, T-bet. The1 cells are experts at 
gearing the immune response towards to the control of internal pathogens like 
viruses and mycobacteria, which reside internally in macrophages. They perform this 
function by initiating cytotoxic T cell responses, helping macrophages to become 
more effective, by helping B cells to produce certain types of antibodies. These 
functions are executed, in part, 14 through IFNȖ exposure; however, some require 
cell-cell contact and will be explained in more detail later37. 
 
ii) T helper 2 Cells 
Th2 cells are created during exposure to high amounts of IL-4. This leads to the 
expression of the Th2-associated master transcription factor, GATA3. Th2 cells are 
also characterized by the production of IL-4 (indeed, the same cytokine needed to 
create them). These cells are designed to skew the immune system towards a 
humoral immune response (antibody response) that can deal with parasite infection. 
Unfortunately, Th2 responses are also the ones associated with allergy development 
as well. Th2 cells do their work by effectively helping B cells and encouraging 
specific forms of antibodies. This is done through a combination of IL-4 exposure 
and cell-cell interactions.  
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iii) T helper 17 Cells 
The Th17 subtype is the most recently described of the Th subtypes. It is 
most effective at controlling extracellular bacterial and fungi responses, like those 
found during intestinal food poisoning or during a yeast infection. Its creation is 
dictated by the cytokines IL-6 and TGFȕ and this leads to the expression of the 
master transcription factor, RORȖt. Th17 cells produce the cytokine IL-17. IL-17 
production is one of the main facilitators of their function and it encourages 
surrounding cells to increase neutrophil migration. Neutrophils are excellent 
phagocytic cells with many bacterial killing tools.38 
iv) Induced Regulatory the cells  
To those just learning about the immune system, the existence of the 
following the subtype may be confusing. I Treg are designed to counter the functions 
of other immune cells. Why? The reason is that immune responses are highly 
damaging to surrounding tissues and, without them, immune responses would spiral 
out of control.  
That said; these cells are induced by DCs when they are exposed to high 
amounts of IL-10 or TGFȕ. This causes the expression of the master transcription 
factor, Foxp3. In turn, iTreg produce IL-10 or TGFȕ. IL-10 and TGFȕ are what is 
called “anti-inflammatory” cytokines. They have the ability to limit the functions of 
immune cells. IL-10, for instance, lowers Th1 and Th17 responses and reduces 
macrophage efficacy. TGFȕ encourages apoptosis (induced death of cells), prevents 
cell division and lowers phagocytosis.39 
 
1.6 Cytotoxic T cell Responses 
Th cells are not the only kind of T cell. Cytotoxic T cells (CTLs), characterized by the 
surface marker CD8, are not to be missed and are essential for the elimination of 
viral infections. The function 15 of a CTL is found in its name. “Cyto” refers to cell 
and “toxic” means just how it sounds. These cells are “cell toxic” and kill other cells. 
In many ways, they are similar to the NK cells and NK T cells of the innate immune 
system. However, they do not use invariant receptors to recognize problems in other 
cells, but instead use an adaptive system.  
CTLs, like Th cells, have a TCR. This means that they can detect unique 
peptides presented to them by other cells. In the case of Th cells, these are MHC 
class II molecules presented via DCs. In the case of CTLs, they are MHC class I 
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molecules. During an infection, as we earlier mentioned, DCs will travel to the lymph 
node and present samples of the intruder to the T cells. This is also happens for 
CTLs. However, despite the presence of all the priming signals, priming will be 
suboptimal. CTLs need an additional signal, jokingly called “the license to kill”. This 
signal is given by a Th1 cell through the production of a cytokine called IL-2, which 
stimulates CTL expansion; and through an interaction between the Th1 cell and the 
DC via CD40 on the DC and CD 40 legend on the Th1 cell, which makes 
the DC more effective at priming CTLs33. Once a CTL is primed and active, it has 
the ability to kill. 
As you can see, CTL activity is highly controlled to ensure that they react only 
to pathogen associated peptides. The reason is that MHC class I can be expressed 
by every cell type in the body. MHC class I on a cell is like a sign advertising the 
health of the cell. The cell is constantly displaying samples of the proteins it’s 
making. If an active CTL recognizes one of these samples as being of viral origin, it 
kills that cell; eliminating a viral host. 
1.7 Adaptive Humoral Immune Responses 
The word “humor” means fluid in Latin and, therefore, humoral immune 
responses relate to noncellular 
Systems found in the bodily fluids. We’ve already discussed non-cellular 
components of the innate immunity; however, in immunology most people are not 
referring to these non-cellular systems when they use the term “humoral immune 
response”. Instead, they are referring to the immune response mediated by 
antibodies and this is part of the adaptive immune response. 
The cell behind antibody responses is the B cell. Naïve B cells of the immune 
system produce rudimentary antibodies (see below) until other cells activate them. B 
cells, unlike the T cells, are not required to interact with DCs; instead B cells reside 
in lymphoid tissues and fish for antigens that they recognize using their B cell 
receptors or BCR. The BCR looks like a surface bound antibody and once it binds a 
molecule, the B cell engulfs it and much like the phagocytes, digests it. Just like the 
DC, the B cell will then present pieces of the antigen to Th cells using MHC class II 
molecules. Primed and activated Th cells, which recognize the presented peptides, 
are then able to “help” the B cell through a 16 CD40-CD40 ligand interaction. The Th 
cell also provides cytokine signals to tell the B cell which kinds of antibodies it should 
make. 
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 This process is reminiscent of the priming process of Th cells. Signal one is 
the MHC class II/peptide and TCR interaction between the B cell and the T cell. 
Signal two is the co stimulatory help provided by the T cell in the form of CD40-CD40 
ligand interactions. And, signal three is the cytokine message provided by the T cell.  
Helped B cells will then further differentiates into plasma cells, which can 
produce massive quantities of antibodies. 
1.8 Antibodies 
 Antibodies by themselves, cause very little harm. However, their strength lies 
in their ability to tag a molecule as harmful and block molecular functions. Antibodies 
enhance the functions of the innate immune system. They can bind to pathogens 
and particles to initiate the complement system and induce phagocytosis. They can 
also block/neutralize molecular interactions. Examples of this function would be an 
antibody that blocks the toxic effects of diphtheria toxin or antibodies the block viral 
binding sites to cells. Antibodies also interact directly with cells and can change their 
function by binding to specific antibody receptors found on the surfaces of immune 
cells40. 
An Antibody is a small protein structure produced by B cells. It is also called 
an immunoglobulin (Ig). It looks like a “Y” and it is formed from four separate 
proteins. Each tip of the “Y” recognizes and sticks to the antigen, meaning that each 
antibody can bind two similar antigens. A single arm is called a Fab (Fragment, 
antigen binding) fragment. The base of the “Y” is called the Fc (Fragment constant) 
region and, while the Fab fragments dictate the specificity of the antigen binding, the 
Fc region dictates the type of antibody or isotype. The antibody isotype is dictated by 
the prevalent cytokines in the environment as well as additional danger signals that 
the B cell experienced while being helped by the Th cell.41 
1.8.1 Rudimentary Antibodies: IgM and IgD 
The first types of antibodies that a B cell can produce are IgM and IgD. The 
“M” and “D” refers to different classes of the Fc region. IgM is found as a pentamer, 
with five individual IgM antibodies bound by their Fc regions in the center forming a 
star. They are effective at complement activation. IgD is found as a monomer and its 
function is undefined. However, it has the ability to bind mast cells via an Fcį 
receptor (į for D) and induce anti-microbial peptide secretion. 
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1.8.2 IgG 
IgG antibodies are found as monomers and they are very potent at stimulating 
immune responses. They are capable of neutralization, inducing phagocytosis in 
macrophages and neutrophils via FcȖ receptors (Ȗ for G), activation of complement, 
and also the activation of NK cells (also via FcȖ receptors).  
 
1.8.3 IgE  
IgE antibodies are monomers. They are known to cause mast cell 
degranulation via binding of Fcİ receptors (İ for E). They are induced during parasite 
infection and, unfortunately, also during allergy.  
1.8.4 IgA  
IgA is found as a dimer of two antibodies attached via their Fc regions. It is involved 
with mucosal defense: found in gastrointestinal system, the respiratory systems. 
They are particularly effective at neutralization of microbes and toxins.  
How the Adaptive Response Strengthens the Innate Response 
 Once the adaptive immune system has formed a response, the body has a 
long-term record of the invading pathogen in the form of long-lived plasma cells, 
memory T cells (not covered here) and antibodies. This is why vaccination is so 
important. It allows your body to create an adaptive immune response against an 
invader without having to truly become infected.42 
When a body encounters a pathogen for the second time, it’s a completely 
different situation than the first encounter. During a second infection, T cells drawn to 
the inflammation site will have knowledge to help macrophages, recruit more 
neutrophils, and kill infected cells. Antibodies will benow present to assist 
complement activation, the phagocytosis of particles, and even kill microbes. The 
response will be quicker and more effective.  
Though separating the two types of responses: innate and adaptive, helps 
with learning; it can also become an obstacle to seeing the immune response as a 
complex, dynamic system. It is important when looking at an immunological problem 
to consider the host’s previous history as it has so much influence on the immune 
response.  
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1.9 Inflammatory response43 
In vivo systems, which involve the whole animals, provide the most natural 
experimental condition, due to their complexity; in vivo systems have a myriad of 
unknown and uncontrollable cellular interactions that add ambiguity to the 
interpretation of data. At the other extreme are in vitro systems, which defined 
populations of lymphocytes are studied under controlled and consequently 
repeatable conditions. 
 
Fig. No 1.3B: Major Events in the local inflammatory response. 
 
 
 
 
 
 
 
 
 
 
 
 
 
1.10 Immune mechanisms  
It is medicated by thymus-derived cells known as T cells, which interact with 
the antigen to reduce lymphocytes. The immune response is an essential defense 
mechanism against the invasion of the body by bacteria. Sometimes the immune 
reaction to an antigen does not only produce antibodies which damage the antigen, 
but may also damage body tissue causing hypersensitivity reactions. These 
reactions are of four types. 
i) Type [Ig E or regain. dependant] reaction  
In this the antigen antibody combination occurs on the surface of the most 
cells & polymorphonuclear leucocytes, & releases pharmacologically active 
substances. This reaction is mediated by the IgE antibodies, which sensitize the 
cells.  
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The onset of type I reaction is within 1-2 minutes, maximal at 15-30 minutes, 
lasts 1½ to 2 hours. 
ii) Type II [cytotoxic tissue – specific antibody] reaction in this the antibody, in the 
presence of complement, reacts with on antigenic component of all cell or tissue, & 
results in cell lysis or damage. This reaction is mediated by IgM or Ig G antibodies. 
iii) Type III [Immune – complex disease, Arthus reaction]  
This is caused by circulating antigen-antibody complexes formed in conditions 
of slight antigen excess, together with complement which can cause tissue 
destruction directly & also by attracting polymorphonuclear neutrophills to the site.  
iv) Type IV [cell-mediated delayed hypersensitivity reactions]  
This immune reaction is mediated by sensitized circulating lymphocytes of the 
T-cell type reacting with antigen. The immune globulins of the type I, II & III reactions 
are not involved in most of the manifestations of the reaction are produced by the 
lymphokines which are soluble factors produced by the sensitized lymphocytes on 
contact with antigen phagocytosis.  
This type of reaction takes 1-2 days to develop after antigen exposure, and 
reaches it is peak at 48-72 hours. E.g. Organ – transplant rejection, contact 
dermatitis, tuberculosis lung reaction and tuberculin skin reactions.  
v) Inflammatory Response 
The final consideration in discussion of defense mechanisms is how the 
nonspecific factors discussed above combine in what is termed the inflammatory 
response to combat an invasion by pathogens. 
 If the microbe is able to activate and fix complement by the alternate 
pathway, the chemotactic complement-derived factors released to attract leukocytes 
to the site, and anaphylatoxin also causes the de granulation of Tissue leukocytes to 
the site and an aphylatoxin also because the de granulation of tissue 20 basophils 
called must cells. These in turn release histamine and serotonin, which cause 
constriction of smooth muscles (e.g., in bronchioles and blood vessels) and 
increased capillary permeability, which promoted the passage of plasma and 
leukocytes into the affected tissue. The leukocytes pass through the junction 
between the capacity endothelial cells in response to the passage of plasma and 
leukocytes into the affected tissue. The leukocytes pass through the junction 
between the capillary endothelial cells in response to the chemotactic influence of 
the complement cleavage fragments. Migration continues until the phagocytes 
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encounter complement fixed to the microbial surface, which causes adherence and 
facilitates engulfment. If antibodies specific for the microbe are present, they 
opsonize it and alsoincrease complement fixation. This greatly enhances leukocyte 
adherence and promote Phagocytosis. The plasma also contains other micro bicidal 
substances, which may inhibit replication and growth of pathogens and modulate the 
subsequent immune response. The symptoms of the inflammatory response are 
local swelling, erythema (reddening), and local and systemic heat. The local swelling 
is due in part to the accumulation of large numbers of phagocytic cells at the site of 
infection. The increase in temperature and the erythema are due to the increased 
blood flow to be local site, enzymatic activity, and the release of bacterial endotoxin  
 
 
Steps In Inflammatory Response 
Fig. No 1.3C: Steps in inflammatory response 
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1.11 Experimental System: 
In vivo systems, which involve the whole animals, provide the most natural 
experimental condition, due to their complexity; in vivo systems have a unknown and 
uncontrollable cellular interactions that add ambiguity to the interpretation of data. In 
vitro systems can be studied effectively, yet they have their own limitation, the most 
notable of which is their artificiality, for example, providing antigen to purified B cells 
in vitro does not stimulate maximal antibody production unless T cells are present.  
 
 
1.12 Experimental Animal Model. 
A study of the immune systems in vertebrates requires suitable animal 
models. The choice of an animal depends on its suitability for attaining a particular 
research goal. If large amounts of antiserum are sought, a rabbit, goat, sheep, or 
horse might be an appropriate experimental animal. If the goal is development of a 
protective vaccine, the animals chose meet be susceptible to the infectious agent so 
that the efficacy of the vaccine can be assessed. Mice or rabbits can be used for 
vaccine development if they are susceptible to the pathogen.  
For most basic research in immunology, mice and Rats have been the 
experimental animals of choice. They are easy to handle, are genetically well 
characterized and have a rapid breeding cycle. The immune system of Rats and 
mice has been characterized more extensively than that of any other species.  
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CHAPTER II 
2. REVIEW OF LITERATURE 
 
Natural immunomodulators Cassia occidentalis 
Mohammed Musa Suleiman et al (2014)47 reported anthelmintic activity of 
cassia occidentalis. Guieri senegalensis standard technique was used to detect 
secondary metabolism to prove in vitro anthelmintic activity, using Hatch inhibition 
test (HETT) and larval development inhibition assay. 
Olufunke Bolatito et al.(2014)48 reported antimalarial screening of Spondian 
mombio, senna occidentalis and Musa sapientum against vibrio cholerao1, the 
tannins flavanoids alkaloids responsible for the anti malarial activity by minimum 
inhibitory concentration and minimum bactericidal and fungicidal concentration. 
Vibrio cholerae O1 can cause large epidemic of cholera with high mortality. This 
study investigated the phytochemical and antimicrobial properties of extracts of 
leaves of Spondias mombin and Senna occidentalis and stem sap of Musa 
sapientum against two epidemic strains of V. cholerae O1 (BA O1 and CVC O1). 
Aqueous and ethanolic extracts of Spondias mombin and Senna occidentalis were 
obtained using soxhlet extraction while the stem sap of M. sapientum was obtained 
fresh. The filtrates were dried at 40 C and stored at 4oC. The crude extracts were 
subjected to phytochemical analysis using standard methods. In vitro antimicrobial 
studies were investigated using microbroth dilution method to determine the 
Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration 
(MBC). Phytochemical analysis revealed the presence of tannins, saponins, 
alkaloids, anthraquinones, flavonoids, cardiac glycosides, phenols and 
phlobatannins. Aqueous and ethanolic leaf extract of Spondias mombin and aqueous 
leaf extract of S. occidentalis have vibriocidal activities with antimicrobial activity 
showing that S. mombin water extract (SMWE) had MIC (41.56mg/ml); and MBC 
(83.13mg/ml) against both BA O1 and CVC O1 respectively while the ethanolic 
extract (SMEE) had MIC (83.13mg/ml); and MBC (166.25mg/ml). Senna 
Occidentalis water extract (SOWE) had MIC (166.25mg/ml); and MBC 
(332.50mg/ml) against BA O1 and CVC O1 respectively. Both aqueous and 
ethanolic extracts of M. sapientum and ethanolic extract of S. occidentalis were not 
effective in vitro on the epidemic strains tested. 31 Spondias mombin and Senna 
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occidentalis could be useful in drug research and development because of the 
photochemical that they possess.  
Komal et al.(2013)49 reported that allellopathic influences of cassia 
occidentalis on growth of zea mays. For evaluating the allelopathic effect of leaf and 
flower extracts of common wasteland weed Cassia occidentalis L. on seed 
germination and seedling growth of Triticum aestivum L. Both extracts inhibited the 
growth of wheat seedlings under laboratory conditions with more pronounced effect 
in case of flower extract. A dose-dependent decrease in growth and dry weight of 
seedlings was observed, however, at lower concentrations, enhancement in seedling 
growth was also recorded.  
Tanimu et al.(2012)50 Acute toxicity test was conducted in a report with 
Cassia occidentalis and found that this plant did not show any hazardous symptoms 
or death . With the sub acute treatment, the Cassia occidentalis does not change 
body weight gain, consumption of food and water and the profiles of hematological 
and biochemical. Also, no changes were seen in macroscopical and microscopical 
aspect of organs in the animals. Thus they conclude that acute or sub acute 
administration of Cassia occidentalis is not toxic.  
Sadiq et al.(2012)51 to evaluated and reported phytochemistry and anti 
microbial activity of cassia occidentalis , preparation of anti-bacterial medium and 
activity tested by using arE well diffusion method. Leaves of Cassia occidentalis 
were extracted with ethanol and water. The extracts were used to carry out 
antimicrobial screening in vitro on staphylococcus aureus, pseudomonas 
aeruginosa, Escherichia coli, salmonella typhi, shigella spp. Chromatographic 
separation was carried out on the active extracts, and the efficacy of the resulting 
fractions was tested against the susceptible organism. Some of the extracts 
indicated significant inhibitory activity against the tested organisms. General 
phytochemical screening was done on the ethanol, water extracts and fractions. 
Ethanol extract revealed the presence of Tannins, Saponins, Cardiac glycoside, 
Terpenoids and Anthraquinones while the fraction revealed the presence of Tannins, 
Terpenoid and Anthraquinones. This result might explain the ethnobotanical use of 
the plant for the treatment of dysentery, gastro internal disorder, constipation and 
Typhoid fever. 
Mohammed et al.(2012)52 reported the anti microbial activity in leaves of 
cassia occidentalis against staphylococcus aurous cultured in nutrient agar, 
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incubation and determined minimum inhibitory concentration and minimum 
bactericidal and fungicidal concentration. 
Srinath Reddy et al. (2012)53 reported anti-anxiety and antidepressant 
activity of ethanolic and aqueous extracts of Cassia occidentalis leaves in rodents. 
Exposing the rats to unfamiliar aversion in different methods like elevated plus maze 
model and actophotometer anti-anxiety activity was tested. Less aversion fear elicits 
anti-anxiety activity. Antidepressant activity was analyzed by despair swim test and 
tail suspension test. Reduced immobility time elicits antidepressant activity. They 
conclude that ethanolic and aqueous extracts of Cassia occidentalis leaves possess 
anti-anxiety and antidepressant activity. Anxiety and Depression are widespread 
psychiatric disorders affecting around 5% of the population. Furthermore, it is difficult 
to predict which patient will respond to any given treatment. In the traditional systems 
of medicine, many plants and formulations have been used to treat anxiety and 
depression for thousands of years. The present study was designed to evaluate the 
anti-anxiety and antidepressant activity of the ethanolic and aqueous extracts of 
Cassia occidentalis leaves in rodents. Antianxiety activity was tested by exposing 
rats to unfamiliar aversion in different methods like elevated plus maze model and 
actophotometer. The results infer that reduced aversion fear elicits anti-anxiety 
activity. The antidepressant activity was tested by using despair swim test and tail 
suspension test. The results infer that reduced immobility time elicits antidepressant 
activity. It was concluded that ethanolic and aqueous extracts of Cassia occidentalis 
leaves having anti-anxiety and antidepressant activity. Ethanolic extract of Cassia 
occidentalis leaves showing more significant activity over the aqueous extract. 
Ravikumar et al. (2011)54 reported antioxidant activity of ethanolic extract of 
cassia occidentalis leaves against carbon tetra chloride induced oxidative stress in 
Wistar rats. The efficacy of ethanolic extract from Cassia occidentalis against CCl4 
induced oxidative stress was tested using wistar albino rats. The antioxidant activity 
was assessed by monitoring the levels of lipid peroxides, antioxidant enzymes like 
glutathione peroxidase, glutathione reductase, glutathione- Stransferase, superoxide 
dismutase and catalase, and non-enzymic antioxidants like reduced glutathione, 
vitamin-C, vitamin-E, cereloplasmin and uric acid in the liver tissues. Administration 
of CCl4 increased the level of lipid peroxides decreasing the activities of enzymic 
and nonenzymic antioxidants. Pre-treatment with ethanolic extract significantly 
prevented the alterations induced by CCl4 and maintained a near normal antioxidant 
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status. Decreased activities of enzymes in CCl4 intoxicated rats and their reversal in 
the ethanolic extract treated rats shows the potency of ethanolic extract in combating 
CCl4 induced oxidative stress. 
Abirami Dhandapani et al (2011)55 reported larvicidal and pupicidal potential 
of Cassia Occidentalis was analyzed in a study against the larvae of Anopheles 
Stephensi. The ethanol extract of Cassia Occidentalis were found to be more 
effective against larva and pupa respectively. The smoke toxicity study was also 
conducted and identified that it was more effective against the Anopheles stephensi. 
Smoke exposed gravid females ovipositor fewer eggs when compared to those that 
were not exposed. A simple High Performance Thin Layer Chromatographic 
(HPTLC) method has been developed for the analysis of flavonoid in ethanol 
extracts of Cassia Occidentalis. The amount of flavonoid in the extracts has been 
estimated by comparing the peak area using the standard. The proposed HPTLC 
method was found to be simple, faster and reliable for analysis of flavonoid. Cassia 
Occidentalis were the dominant invasive weed in the campus of Bharathiar 
University India. Their allelopathic activity has greatly affected the phytodiversity in 
the campus. With the view of their huge biomass prospecting, the larvicidal potential 
of ethanol extract of Cassia Occidentalis was tested against the larvae of Anopheles 
Stephensi. The ethanol extract of Cassia Occidentalis were found most effective with 
LC50 value of 60.69%, 64.76%, 67.78%, 70.56%, 92.21% of I, II, III, IV and pupa 
respectively. The smoke toxicity was more effective against the Anopheles 
stephensi. Smoke exposed gravid females oviposited fewer eggs when compared to 
those that were not exposed. 
Karpakavalli et al56. reported analgesic and antipyretic activity of cassia 
occidentalis. Ethanol and water extracts of Cassia occidentalis leaves were screened 
in mice which were induced b acetic acid and tested for hot plate and tail immersion 
assay. The ethanol and water extracts possess antinociceptive and antipyretic 
properties. Highest inhibition dose was found to be as 300 mg/kg56. 
Prabh et al. (2011)57 reported anti diabetic activity of leaves of cassia 
occidentalis using alloxan induced hyperglycemia and quantitatively estimated blood 
glucose level. Many plants synthesize substances that are useful to the maintenance 
of health in humans and other animals. These include aromatic substances, most of 
which are phenols or their oxygen-substituted derivatives such as tannins. Many are 
secondary metabolites, of which at least 12,000 have been isolated — a number 
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estimated to be less than 10% of the total. In many cases, substances such as 
alkaloids serve as plant defense mechanisms against predation. Diabetes mellitus 
often simply referred to as diabetes—is a condition in which a person has a high 
blood sugar (glucose) level as a result of the body either not producing enough 
insulin, or because body cells do not properly respond to 34 the insulin that is 
produced. Insulin is a hormone produced in the pancreas which enables body cells 
to absorb glucose, to turn into energy. Cassia occidentalis is an annual shrub. The 
leaves, roots & entire plant as such has been used in various countries like China, 
Brazil, Sri Lanka & India in the treatment of the variety of ailments such as malaria, 
liver diseases, fungal infections etc. Thorough literature survey for the chemical 
nature of the plant reveals that the plant contains quinines, flavonoids, saponins and 
alkaloids. The ethno medical information reveals the plant has been used to treat 
diabetes. 
             Emmanuel et al. (2010)58 reported that anti diabetic activity of leaves of 
cassia occidentalis in streptozotocin induced diabetics in rats, a dose dependent 
study calculated. Acute toxicity study and experimental induction of diabetics in rats. 
Cassia occidentalis Linn is extensively used in the indigenous and folklore medicine 
systems to treat several illnesses. However adequate characterization of 
hypoglycemic activity of C.occidentalis has not yet been done. The scientific 
evaluation of its hypoglycemic activity was, therefore, explored and also compared 
with the effect of a standard hypoglycemic drug, Glibenclamide. In the present study 
methanol fraction of C.occidentalis leaves (COLMF) was tested against 
streptozotocin-induced diabetic rats. Adult male albino Wistar rats, weighing 150-
200g, were randomized into control and experimental groups. Experiment group rats 
were induced diabetes by a single intraperitoneal injection of streptozotocin (STZ). 
Treatment with COLMF at different doses and times following in normal and diabetic 
rats significantly reduced the blood glucose level to normal in diabetic rats 
(99.68±3.57). Hemoglobin, glycosylated hemoglobin, hepatic glycogen, lipid 
peroxidation, antioxidants enzymes (TBARS, HP, SOD, CAT, GPx VitC, VitE, and 
GSH) and hepatic marker enzymes (ALT, AST, ALP, ACP) were also evaluated in 
normal and diabetic rats. Oral administration of COLMF significantly and dose-
dependently normalized the above mentioned parameters near to normal in STZ-
diabetic rats (p<0.05). Histopathological examination showed that COLMF extract 
protected the pancreatic tissue from STZ-induced damage. 
 25 
 
Bilal Bin-Hafeez et al.(2001)59 reported that Immunosuppression 
,cyclophosphamide (CP) was administered intraperitoneally in a single dose of 50 
mg/kg b.w. Body weight, relative organ weight, lymphoid organ cellularity, 
hemagglutination titer (HT); plaque forming cell (PFC) assay and quantitative 
hemolysis of SRBC (QHS) were analyzed in animals. It has suppressive effectson 
lymphoid organ weight and cellularity and other parameters of humoral immunity. 
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CHAPTER III 
3. AIM AND OBJECTIVE 
 
                  The effective drugs are not available for the treatment of certain 
infections like AIDS, hepatitis, and other viral infections. For other infections the drug 
(mainly antibiotics) being used are becoming ineffective due to development of 
microbial resistance, necessitating the search for newer drugs. Any such new drug 
will be available only at an exorbitant cost due to the product patent norms under 
WHO agreement  
In Siddha, Ayurveda and other ancient systems of medicine, many plants and 
plant preparations are reported to be useful in the treatment of infections. When 
screened by modern scientific methods these preparations did not show any 
immunomodulatory activity.  
These drugs may not probably act directly upon the microbes. Instead may 
stimulate the body’s defense mechanism (immune system) and thereby help to cure 
the infection. 
Hence by screening herbal drugs and their extracts for their immunostimulant 
property it may be possible to get effective, cheaper new molecular entity for the 
treatment of various infections.  
It may be hoped that such type of drugs will not produce microbial resistance, 
since they do not act on the microbes and will not have adverse side effects since 
they are from (natural) plant origin. 
This work is to prove the Immunomodulatory property of Cassia occidentalis 
in Wistar rats by studying the Delayed Type Hypersensitivity (DTH), Humoral 
Antibody titre (HA), Total Leukocyte Count (TLC), and Differential Leukocyte Count 
(DLC) In the Aqueous Extract of Cassia Occidentalis leaves extract. 
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CHAPTER IV 
4. PLAN OF WORK 
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CHAPTER V 
5. PLANT PROFILE 
 
5.1 Description of the Plant 
 
Botanical name   :   Cassia occidentalis 
5.1.1 Taxonomic Hierarchy8 
Kingdom    :   Plantae 
Subkingdom    :  Angiosperm 
Super division   :  Eudicots 
Class     :   Dicotyledonae 
Subclass    :   Rosidae 
Order     :  Fabales 
Family    :   Fabacae 
Genus                        :  cassia 
Species    :   Cassia occidentalis  
 
5.1.2 Vernacular names 
Common name  :  Coffee senna 
Tamil                                   :                    Nattam takarai 
Hindi     :  Kasunda 
Kannada    :  Kolthogache 
Sanskrit    :  Kasamarda 
Malayalam    :  oolanthakara 
 
 
5.2 Botanical Description 44 
           C.occidentalis is an erect, somewhat branched, smooth, semi-woody, fetid 
herb or shrub, 0.8 1.5 m tall, taproot, hard, stout, with a few lateral roots on mid-
section. This plant species varies from a semi-woody annual herb in warm temperate 
areas to a woody annual shrub or sometimes a short-lived perennial shrub in frost 
free areas. The stem of the plant is reddish purple. The young ones are 4-sided, 
becoming rounded with age. Leaves are alternate, even pinnately compound, each 
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one with 4–6 pairs of nearly sessile, opposite leaflets, with a fetid smell when 
crushed, each leaflet 4–6 cm long, 1.5–2.5 cm wide, ovate or oblong, lanceolate with 
a pointed tip and fine white hairs on the margin. The rachis has a large, ovoid, 
shining, dark purple gland at the base. Stipules are 5–10 mm long, often leaving an 
oblique scar. Inflorescence is a compound of axillary and terminal racemes. The 
flower is perfect, 2 cm long with 5yellowish green sepals with distinct red veins and 5 
yellow petals. The fruit is a dry, dehiscent, transversely partitioned, faintly recurred, 
laterally compressed, sickle shaped legume (pod), 7–12 cm long, 8–10 mm wide, 
with rounded tip and containing 25–50 seeds. Seeds are oval shaped, 3.5–4.5 mm 
wide, flattened; pale to dark brown, slightly shiny, smooth and with a round pointed 
tip.  
 
 
Fig. No 5A: Cassia occidentalis 
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5.3 Chemical constituents45 
                     Achrosin, aloe-emodin, emodin , anthraquinones), anthrones, apigenin, 
aurantiobtusin, campesterol, cassiollin, chryso-obtusin, chrysophanic acid, 
chrysarobin, chrysophanol , chrysoeriol, emodin, essential oils, funiculosin, 
galactopyranosyl, helminthosporine , islandicine, kaempferol, lignoceric acid, linoleic 
acid, linolenic acid, mannitol, mannopyranosyl, matteucinol, obtusifolin, obtusin, oleic 
acid, physcion , quercetin, rhamnosides, rhein, rubrofusarin, sitosterols, tannins, and 
xanthorine 
 
5.4 Parts used 
Leaves, roots and seeds. 
 
5.5 Properties and Used46 
 Decoction of plant is used as hysteria, in dysentery and other stomach 
troubles. 
 Leaves is mixed with calcium hydroxide is applied to dresses. 
 Leaves powder is mixed with salt and onion poultices to gunea worms. 
 Ointment of leaves is used as skin diseases. 
 Decoction of leaves is used as blood purifier. 
 Leaves internally and externally used skin diseases.. 
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CHAPTER VI 
6. MATERIALS AND METHODS 
                                                                                                                                            
6.1 Chemicals and Drugs: 
 The Sheep Red Blood Cells (SRBCs) were procured from U WIN Life 
science,Malappuram 
 The Levamisole (Cipla Limited- India) was purchased from local pharmacy, 
Malappuram. 
 The Humoral antibody test, TLC, Differential leukocytes tests were performed 
in UWIN Life Sciences. All chemicals were procured from UWIN Life 
sciences,Malappuram. 
 
6.2 Collection of Plant Materials: 
             The dried leaves of Cassia occidentalis belonging to the family Fabaceae 
were collected from the Botany Central Council for Research in Ayurvedic and 
Siddha Govt. of India (NO:UWAU/351/16) and authenticated by  Chelladurai.V 
research officier Botany Central Council for Research in Ayurvedha and Siddha 
Govt. of India 
6.3 Preparation of Aqueous Extract60 
            The leaves will be cleaned with deionizer water, oven dried at 500C for 48 
hours and powdered in a grinder. The plant material (200 gm) will be sequentially 
extracted with water (2000 ml) by using Soxhlet apparatus for 24 hours at a 
temperature not exceeding the boiling point of the solvent. The obtained extracts will 
be filtered by using Whatmann No. 1 filter paper and then concentrated under 
vacuum at 400C by using a rotary evaporator. The extract will be then lyophilized 
(Allied Frost lyophilized) to powdered form at 550C under vacuum conditions. The 
extractive value of the extracts (percentage yield) will be calculated. The residual 
extracts will be stored in refrigerator at 40C in small and sterile plastic bottles. 
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6.4 Acute Toxicity Study61 
                   Acute toxicity for aqueous extract of leaves will be done according to the 
Organization of Economic Co-Operation and Development (OECD) guideline No: 
423.The overnight fasted rat is weighed and selected. The extracts will be dosed in a 
stepwise procedure, with the use of 6 animals of a single sex (normally females) per 
step. Absence or presence of compound-related mortality of the animals dosed at 
one step will determine the next step (i.e. no further three additional animals at the 
next higher or lower dose level). The starting dose level is selected from one of four 
fixed levels (5, 50, 300, and 2000) and it should be that which is most likely to 
produce mortality in some of the dosed animals. . Hence 200 mg/kg and 400 mg/kg 
b.w of cassia occidentalis extract were taken as effective doses for evaluation of 
immunomodulatory activity. 
6.5 Expeimental Animals 
Wistar rats (average body weight 150-200g), used from in house laboratory. The 
animals were maintained under standardized environmental conditions (22-28oC , 
60-70% relative humidity, 12 hr dark/light cycle) in animal house, Department of uwin 
life science malappuram. The animals were provided with standard mouse chow 
(SaiDurga Feeds and Foods, Bangalore, India) and water ad libitum. All animal 
experiments were conducted during the present study got prior permission from 
Institutional Animal Ethics Committee (IAEC approved) and following the guidelines 
of Committee for the Purpose of Control and Supervision of Experiments on Animals 
(CPCSEA) constituted by the Animal Welfare Division, Government of India (No:-
KU/IAEC/M.pharm/171) 
6.6 Experimental Protocol:  
24 rats were divided into four groups of six animals each. 
Group-I: Control: 
Group-II: Cassia occidentalis aqueous extract was administered at a dose 
200mg/kg/day by oral route for 14 days 
Group-III: Cassia occidentalis aqueous extract was administered at a dose of 
400mg/kg/day by oral route for 14 days 
Group-IV: Standard – Levamisole was administered at a dose of 50mg/kg/day by 
oral route for 14 days 
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6.7 Experimental Setup 
The animal model is required to study the following 
1. Delayed type hypersensitivity (DTH) response 
2. Humoral antibody (HA) titer 
3. Total leukocyte count 
4. Differential leukocyte count 
 
1. Determination Of Delayed Type Hypersensitivity Response (DTH)23 
              The fresh sheep blood was collected from U WIN life science. It was 
washed three times with normal saline via centrifugation. The suspension was 
adjusted to 1 X108.The animals were immunized by injecting 0.1 ml of SRBCs 
suspension, containing 1X 108 cells (1.0 X 108SRBC/ml) intraperitonially, on day 0. On 
Day 8, after immunization the thickness of the right hind footpad was measured 
using a Vernier caliper. The rats were then challenged by injection of 1 X 10 8sub 
SRBCs in the left hind footpad. The footpad thickness was measured again after 24 
hours of challenge. The difference between the pre- and post-challenge footpad 
thickness, expressed in mm was taken as a measure of the DTH response. The 
following formula to be used to measure the DTH response. 
 
                   (Left foot pad challenged with antigen-Right foot pad control) 
X100 
                                     Left foot pad challenged with antigen 
 
2. Humoral Antibody Titer62 
                The animals were immunized by injecting 0.1 ml of SRBCs suspension, 
containing 1X 108 cells, intraperitoneally, on day 0. Blood samples were collected in 
micro centrifuge tubes from individual animals of all the groups by retro orbital vein 
puncture on day 10. The blood samples were centrifuged and the serum separated. 
Antibody levels were determined by the hemagglutination technique. 
2.1 Method for Serial dilution 
                     This was performed by using 96 wells (12x8) U bottomed titre plate. 
The wells were marked from I to XII. In the first (I) and last well (XII) 25 micro liter of 
serum collected from treated animals was added and inactivated at 56 degree 
Celsius for 30 minutes. Afterwards to all the wells except well number XII, 25 micro 
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liter of PBS was added.25 micro liter was taken from first well and added to 2nd well 
again 25 micro liter from second well was taken and added to third well and 
continued the same procedure up to well number XI. After this 25 micro liter of 
sample from well number XI was discarded. Finally 25 micro liter of 1% SRBC was 
added to all the wells and was kept at room temperature for two hours. 
Observation: 
          The button formation was observed. The well which is previous to the well 
showing button formation is considered as Antibody titer. 
Table No:1  Dilution 
Well no Dilution(antibody 
titer) 
1 2 
2 4 
3 8 
4 16 
5 32 
6 64 
7 128 
8 256 
9 512 
10 1024 
 
 
3.Total Leukocyte Count63 
3.1 W.B.C diluting pipette: 
            It has got three graduations. Two graduations 0.5 and 1 are present on the 
stem of the pipette and the third mark 11 is placed just above the bulb. Blood is 
drawn up to mark 0.5 and the rest of the bulb is filled by sucking up diluting solution 
up to the mark 11, the bulb of the pipette is so constructed that it holds exactly 20 
times the volume of fluid contained in the stem of the pipette up to mark 1.Although 
fluid is drawn up to 11, the dilution of the blood will be 20 because the last part of the 
fluid remains locked up in the stem and is not available for dilution. 
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3.2 Counting chamber: 
             The ruling area consists of 9 square millimeters. The central of the smallest 
squares are separated by triple lines in which RBC will be counted. The side of each 
square for counting WBC is ¼ mm. 
 
3.3 Diluting fluid for WBC (Turks fluid) 
Commonly the fluid is made up as follows: 
Glacial acetic acid     -1.5ml 
1%solution of gentian violet in water  -1ml 
Distilled water     -98ml 
The glacial acetic acid hemolysis the red cells, while the gentian violet stains the 
nucleus of Leukocytes 
 
3.4 Method of counting W.B.C 
          The white cells are counted in four corners of 1 square millimeter ruled area 
on both sides. The white cells are recognized by the retractile appearance and by 
the slight color given to them by the stain contained in the diluting fluid. The cells 
touching the left side and upper side of boundary line are not counted. 
 
3.5 Calculations: 
The area of the smallest square              =  1/16 mm3square 
Volume of smallest square    =  1/160 mm3 
Total number of square counted              =  16×4=64 
Total number of cells counted              =   X 
64/160 mm3 of diluted blood contains             =  X cells 
So, 1 mm3 of diluted blood contains   =  160/64 × X cells 
1 mm3 of undiluted blood contains  =  160/64 × 20 × X cells 
 
4 Differential Leukocyte Counts64                                                      
          A thin blood film was made on a clean, dry, glass slide. It was dried fixed and 
stained to differentiate the different types of leukocytes. Hundred leukocytes were 
counted and percentage of different leukocytes was calculated  
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4.1 Composition of leishman’s stain  
It contains a mixture of methylene blue and eosin dissolved in acetone free 
methanol. 
4.2 Procedure 
                  A thin blood film was made on a clean dried glass slide. It was dried and 
stained with leishman’s stain solution. The drop of leishman’s stain was counted & 2 
minutes was allowed to fix the blood film. Fixation means nucleus and various 
cellular organs will be fixed without any damage to the cells or cellular organs. After 
2 minutes double the quantity of distilled water was added over the slide and waited 
for 7 minutes. In the meantime the stain will initiate the chemical reaction. The acidic 
dye eosin will initiate various acidophilus structures and some neutrophyllic granules 
and basic dye will stain structure like nucleus, basophilic granules, and cytoplasm of 
the lymphocyte and monocytes. After 7 minutes the slide was washed in a slow 
stream of water later it was dried in air. One drop of cedar wood oil was placed over 
the film. The cells were identified and entered into 100 squares. This gives the % of 
different types of leukocytes present in rat blood. 
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CHAPTER VII 
7. RESULTS AND DISCUSSION 
                        Effects of Test Extracts and Standard Drug on DTH Response in rats 
Using Sheep’s RBCs as Antigen. The effect of test extract and standard drugs on the 
DTH response in wistar rats using SRBCs as antigen, administration of aqueous 
extract of Cassia occidentalis at the dose of 200mg/Kg and 400mg/Kg and 
Levamisole 50mg/Kg treatments which were given orally for 14 days showed 
significant increase in paw edema compared to control group. The standard drug 
Levamisole showed the maximum increase in paw edema volume compared to all 
groups. The results are shown in below 
 
Table no.7.1: Effects of Test Extracts and Standard Drug on DTH Response in 
Rats Using Sheep’s RBCs as Antigen. 
Group Treatment Dose DTH 
Response (mm) mean paw 
edema 
 
I Control  2.48±0.235 
II Test extract I Cassia occidentalis 200 
mg/kg 
 
3.25±0.2658* 
 
II Test extract II Cassia occidentalis 400 
mg/kg 
 
4.53±0.2416** 
 
III Standard Levamisole 50mg/kg 4.71±0.1560*** 
 
 
Dunnett test and p values as significant* if p<0.05, highly significant** if p<0.01 and 
extremely highly significant*** if p<0.001 as compared to control  
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7.1A Delayed Type Hypersensitivity Reaction 
 
Fig. No.7.1A: Delayed type hypersensitivity reaction 
 
 
 
Group I    :   Control 
Group II   :  Cassia occidentalis 200 mg/kg 
Group III:    Cassia occidentalis 400 mg/kg 
Group IV:    Levamisole 50 mg/kg 
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Fig. No.7.1B Paw edema observed in animals after injecting sheep’s RBC 
Control Animal 
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Fig. No.7.1C Cassia occidentalis 200 mg/kg 
 
 
 
 
 
 
 
 
 
 
 
 41 
 
Fig. No.7.1D Cassia occidentalis 400 mg/kg 
 
Fig. No.7.1E Levamisole 50 mg/kg 
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Delayed Type Hypersensitivity Reaction 
Fig No. 7.2 B: Delayed Type Hypersensitivity Reaction 
 
 
   Cassia occidentalis reduce the paw edema by using the extract in different 
concentration, by the Delyed hypersensitivity reaction. In this method SRB’S antigen 
study shows DTH response will be increased. Mean percentage increased paw 
volume directly proportional to increase the concentration, nearly to the reference 
compound.     
In order to understand the possible mechanism of action at cellular level, the effects 
of Cassia Occidentalis were studied on cell mediated host defense system by 
Delayed Type Hypersensitivity reactions (DTH) in rat model, since it is predominantly 
T-cell mediated immune reactions. DTH response is triggered by IFN-Ȗ produced by 
CD4+, a Th1 (thymus derived helper cell) cells or CD8cells72. These cells take at 
least 24-72 h for the induction as well as T-cells activation which subsequently 
recruits monocytes and lymphocytes to the desired site for enhanced immune 
responses. Furthermore, DTH response is known to be initiated by interactions 
between antigen specific T-cells and antigen, causing the secretion of lymphokines 
which affects immune cells, especially macrophages. The DTH response largely 
represents the enhancement of lymphoproliferative events73.In these experimental 
findings too, reduction of DTH response with the treatment of, Cassia Occidentalis 
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suggesting the increased proliferation and differentiation of Th1 cells. Such cellular 
events finally results in increased production of cytokines viz. IL-2, IL-6, IL-12, IFN-Ȗ 
and TNF-α10-12. It is established that, IL-12 and TNF-α plays a vital role in both 
innate and adaptive immunity, therefore, it is worthwhile to mention here that 
enhanced production of TNF-α and Nitric Oxide (NO) are vital component of immune 
system which are participating in the protection of intracellular infections. Hence, it is 
likely that treatment Cassia Occidentalis elicit significant immunomodulatory 
activity74. 
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7.2 Mean Humoral Antibody Titer 
The effect of test extract and standard drugs on the Humoral Antibody Titer in 
Wister rats 
Administration of aqueous extract of cassia occidentalis at the dose of( 200& 400 
mg/kg )and Levamisole 50mg/Kg treatments which were given orally for 14 days 
showed highly significant increase in antibody titer values compared to control group. 
The results are shown in below table: 
 
Table No 7.2: The effect of test extract and standard drugs on the Humoral 
Antibody Titer in wistar rats 
 
 
Group Treatment Dose Antibody titer 
means ±sem 
 
I Control  9±1.897 
II Test extract I Cassia occidentalis 
200 mg/kg 
339.57±76.43 
 
III Test extract II Cassia occidentslis 
400 mg/kg 
417±138.65 
 
IV Standard Levamisole 50 
mg/kg 
452±132.14 
 
 
 
 
Dunnett test and p values as significant* if p<0.05, highly significant** if p<0.01, and 
extremely highly significant*** if p<0.001 as compared to control 
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Humoral Antibody Titer 
Fig. No 7.2A: Humoral antibody titer 
     
Group I   : Control 
Group II  : Cassia occidentalis 200 mg/kg 
Group III : Cassia occidentalis 400 mg/kg 
Group IV : Levamisole 50 mg/kg 
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Micro Titer Plate 
 Fig. No 7.2B Control 
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Fig. No 7.2C Cassia occidentalis 200 mg/kg 
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Fig. No 7.2D Cassia occidentalis 400 mg/kg 
 
Fig. No 7.2 E Standard drug – Levamisole 50 mg/kg 
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Humoral Antibody Titer 
                                        Fig. No 7.3.Humoral Antibody Titer 
 
          Mean humoral antibody titer value increased proportional to the concentration.        
In addition, the effects of Cassia Occidentalis on antibody mediated humoral immune 
response were studied by determining antigen-antibody HA titer. Scientific evidence 
suggests that, there is an increased immunoglobulin formation which is considered 
to be an indicator of primary effector function of B-cells75.The augmentation of 
humoral response to SRBCs with the treatment of Cassia Occidentalis was 
manifested in the form of increased HA titer. Such improved HA response can be 
explained by taking into account that IgM is more effective than IgG in agglutinating 
red blood cells. The increased HA titer with the treatment of Cassia Occidentalis 
likely to prove an important paradigm for evaluating improved immune reactions, that 
might have been achieved through the activation of lymphoid cells76.Thus, present 
experimental findings with DTH and HA titer clearly demonstrated that the treatment 
of Cassia Occidentalis enhanced the proliferation of T cell and B-lymphocytes, 
ultimately leading to improvement of both the arms of immunity (innate and adaptive 
immunity).77,78 
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7.3 Total Leukocyte Count 
The effect of test extract and standard drugs on Total Leukocytes in wistar rats, 
administration of aqueous extract of Cassia occidentalis at the dose of (200,400 
mg/kg) and Levamisole 50mg/Kg treatments which were given orally for 14 days. 
The low dose of extract (200 mg/kg) did not show any effect on TLC count compared 
to control group, whereas the 400mg/Kg and standard drug Levamisole 50mg/Kg 
showed significant increase in total leukocytes count values compared to control 
group. The results are shown in below table: 
 
Tabel No 7.3: Total leukocyte count 
Group Treatment Dose Mean leukocyte 
count±sem 
I Control  5.01×103/cu.mm±0.296 
II Test extract I Cassia occidentalis 
200 mg/kg 
6.89×103cu.mm±0.248* 
 
III Test extract II Cassia occidentalis 
400 mg/kg 
9.41×103cu.mm±0.31** 
 
IV Standard Levamisole 50 
mg/kg 
14.6×103cu.mm±0.138 
 
Dunnett test and p values as significant* if p<0.05, highly significant** if p<0.01, and 
extremely highly significant*** if p<0.001 as compared to control. 
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Total Leukocyte Count 
Fig No. 7.3A: Total leukocyte count 
 
A : Control 
B : Cassia occidentalis 200mg/kg 
C : Cassia occidentalis 400mg/kg 
D : Levamisole 50 mg/kg 
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Total  Leukocyte Count 
 
Fig No. 7.4: Total leukocyte count 
 
 
Value of mean humoral antibody titre, total leuckocyte count and differential 
leukocyte count will be increased on the basis of concentration. In present study 
cassia occidentalis increase the immunity and reduce the solid tumor volume in 
presence of radiation. 
7.4 Differential Leukocyte Count 
The effect of test extract and standard drugs on Differential Leukocytes count in 
Wistar rats, administration of aqueous extract of cassia occidentalis at the dose of 
(200,400 mg/kg) and Levamisole 50mg/Kg treatments which were given orally for 14 
days. 
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   a) For the differential leukocyte count, the lower dose 200mg/Kg of cassia 
occidentalis showed no increase in mean percentage of lymphocytes, Eosinophils 
and Neutrophils values as compared to control. 
   b) The results obtained from the animals that received higher dose of aqueous 
extract i.e. 400mg/Kg and standard drug Levamisole 50mg/Kg showed the fact there 
was a highly significant increase in the mean percentage of lymphocytes and 
significant increase in the mean percentage of Neutrophils respectively when 
compared to control. There is no effect in mean % increase in Eosinophils count 
even in 400mg/Kg dose of aqueous extract of cassia occidentalis and standard 
Levamisole-50mg/Kg compared to control group. The results were shown below 
table 
 
Table no 7.4 Differential leukocyte counts 
Group Treatment Dose Mean % 
of 
lymphocytes 
 
Mean % of 
Neutrophils 
 
Mean % 
of 
Eosinophils 
I Control  26.4±0.916 66.71±0.431 5.21±0.08 
II Test extract 
I 
Cassia occidentalis 200 
mg/kg 
29.21±0.431 69.54±0.42 5.60.141 
 
III Test extract 
II 
Cassia occidendalis 400 
mg/kg 
36.1±0.34 75.08±0.546 6.5±0.01 
 
IV Standard Levamisole 50 mg/kg 37.98±0.685 79.48±0.71 7.01±0.483 
 Dunnett test and p values as significant* if p<0.05, highly significant** if p<0.01, and 
extremely highly significant*** if p<0.001 as compared to control 
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Differential Leukocytes Count 
 
Percentage of lymphocytes 
Fig. No 7.4 A Differential Leukocyte Count
Percentage of lymphocytes  
Fig. No 7.4 B Percentage of lymphocytes 
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Percentage of Eosinophils 
Fig.No  7.5A: Percentage of Eosinophils 
 
Percentage of Eosinophils 
Fig.No  7.5A: Percentage of Eosinophils 
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Percentage of Neutrophils 
Fig. 7.6A Percentage of Neutrophils 
Percentage of Neutrophils 
Fig. 7.6 B: Percentage of Neutrophils 
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                    During inflammation neutrophils produce super oxide and other highly 
reactive oxygen products capable of inducing cell injury. Stimulation of neutrophils 
also induced release of granules containing lysosomal enzymes which results in cell 
injury. The flavanoids and steroids are present in the cassia occidentalis this may 
responsible to produced anticancer and immunomodulatory activity.  
        Modulation of the immune functions either by stimulation or suppression may 
help to maintain a disease-free state65.Medicinal plants used in traditional medicines 
are demonstrated to modulate either cellular or humoral or both arms of the immune 
responses of the body66. Plants contain several chemical constituents, of which 
some constituents may have immunosuppressive activity, whereas others possess 
immunostimulatory action67. The biological activity of a plant extract is greatly 
dependent on its chemical nature, composition and structure of the major active 
metabolites68. Therefore, the quantitative determination of specific known bioactive 
compounds in herbal medicines is essential for quality control and dose 
determination in the toxicological and biological activity studies. The leukocytes 
including neutrophils, lymphocytes, monocytes, eosinophils and basophils are 
involved in the development of an immune response69.Of these cells, lymphocytes 
are the hallmark of an immune response because of its diversity, specificity, and 
memory and self/non-self-recognition characteristics. All the other cells play 
accessory roles like activation lymphocytes, stimulation of antigen clearance by 
phagocytosis, secretion of various immune effector molecules. The hematopoietic 
action of a plant extract is demonstrated to be a direct action on the hematopoietic 
stem cells70.In TLC and DLC counts, Cassia showed a dose dependent increase in 
TLC count and populations of monocyte and lymphocyte in rats .The possible 
immunostimulatory effect of Trigonella was evidenced by an increase in the TLC 
count with the increase in the population of monocytes and lymphocytes.71 
Herbal drugs entitled as ‘Rasayana’ are known to possess immunomodulatory 
properties and known to act by stimulating both specific and non-specific immunity79. 
In DTH, antibody formation against the antigen, SRBCs requires co-operation of 
immune cells derived from T, B lymphocytes and macrophages80. Furthermore, 
SRBCs cause mature T-cells to differentiate into 3 distinct functioning subsets, 
discriminated according to the array of cytokines they produce: Th1 cells secrets IL-
2, IFN-Ȗ and tumor growth factor-ȕ, Th2 cells produce IL-4, IL-5 and IL-6. Th0 cells 
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have the capacity to produce both Th1 and Th2cytokines, since they represent a 
stage of differentiation prior to their commitment to the Th1 or Th2 lineage.81 
In context to the aforementioned events, macrophages are responsible for secretion 
of IL-1, Il-6, IFN-Ȗ and TNF-α upon their activation15-1782. TNF-α is a principal 
mediator of acute inflammation inducing cytokines release following CYP 
administration. The level of TNF-α in the serum of both immune suppressed and 
SRBCs challenged rats were found to be reduced with the treatment which is 
contradictory to the above statement. Since, such findings have been reported which 
may be explained on the basis of biphasic action of TNF-α in immune modulation 
process83. The rats treated with Cassia Occidentalis also showed a decreased TNF-
α level which may also be attributed to similar action 
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CHAPTER VIII 
8. SUMMARY AND CONCLUSION 
       The study was undertaken to carry out the Immunomodulatory activity of 
aqueous extract of Cassia occidentalis. For the experimental work the dried leaves 
were powdered and extracted with distilled water and was frozen dried. The aqueous 
extract of Cassia occidentalis in two different doses 200mg/kg and 400mg/kg were 
tested for their Immunomodulatory action, out of which the higher dose of 400mg/kg 
showed statistically significant Immunomodulatory activity. This was evident from the 
different parameters that were measured. 
Delayed Type Hypersensitivity Response 
In this parameter the both lower dose and higher dose of the test (200 mg and 400 
mg/kg) had shown significant result in increase in paw edema when compared with 
control. The standard drug Levamisole had shown the maximum increase in paw 
volume. 
Humoral Antibody Titer 
In this parameter both the dose of 200 mg/kg and 400 mg/kg of cassia occidentalis 
produced significant result, standard drug Levamisole at a dose of 50 mg/kg also 
produced significant increase in the titer value. 
Total Leukocyte  Count 
 In this parameter the lower dose of Cassia occidentalis 200 mg/Kg had 
shown no significant increase and higher dose of the aqueous extract of Cassia 
occidentalis 400 mg/Kg showed a highly significant increase in the mean total 
leukocyte count, as compared to control. The results were highly significant for the 
standard drug Levamisole 50 mg/kg as compare with the test and control group. 
Differential Leukocyte Count 
 For the differential leukocyte count the results revealed for lower dose of 
cassia occidentalis showed no significant increase in mean percentage of 
lymphocytes, Eosinophils and Neutrophils increase in values as compared to control. 
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 The results obtained from the animals that received higher dose 
(400mg/kg) of aqueous extract, revealed the fact there was a highly significant 
increase in the mean percentage of lymphocytes and significant increase in the 
mean percentage of neutrophils respectively when compared to control. The effect of 
this extract were comparable to the standard drug levamisole all the data represents 
the Immunostimulatory activity of aqueous extract of Cassia occidentalis 
                        The results of present study revealed that the aqueous extract of 
leaves of Cassia Occidentalis generally shown immune stimulatory effect on the 
humoral immune function and cell mediated immunity in Wistar rats. Further, Studies 
are required to gain more insights into the possible mechanism of action 
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